Mysterious tuft cells found to play role in pancreatitis

April 17, 2020

LA JOLLA--(April 17, 2020) Persistent inflammation of the pancreas (chronic pancreatitis) is a known risk factor for developing pancreatic cancer, the third-deadliest cancer in the United States. Tuft cells--cells sensitive to chemical (chemosensory) changes typically found in the intestines and respiratory tract--had previously been discovered in the pancreas, but their function has largely remained a mystery. Now, a team of Salk scientists led by Professor Geoffrey Wahl and Staff Scientist Kathleen DelGiorno has uncovered the formation of tuft cells during pancreatitis and the surprising role of tuft cells in immunity, using mouse models of pancreatitis. The findings, published in Frontiers in Physiology on February 14, 2020, could lead to the development of new biomarkers to test for pancreatitis and pancreatic cancer.

"By understanding these early stages of pancreas disease, we hope our work will lead to the development of new strategies to diagnose and treat pancreatitis and pancreatic cancer early on," says Wahl, co-corresponding author and holder of the Daniel and Martina Lewis Chair in Salk's Gene Expression Laboratory.

The pancreas is an abdominal organ that plays a role in digestion and blood sugar regulation. Yet, scientists know little about how the pancreas recovers from injuries, such as pancreatitis, or fights off pancreatic cancer. Most of the pancreas is composed of acinar cells, which produce and secrete digestive enzymes. Acinar cells also have the ability to transform into another type of cell called a tuft cell. Scientists do not know all of the functions of tuft cells, but previous work showed that intestinal tuft cells secrete the protein IL-25 to support the immune response during parasitic infections.

"Since cancer has been called 'the wound that never heals,' we wanted to investigate how the pancreas heals from pancreatitis to better understand pathways that may be co-opted by cancer," says Razia Naeem, co-first author and laboratory technician in the Wahl lab.

The researchers used a combination of techniques including histology, imaging and molecular strategies to characterize tuft cell populations in pancreatitis mouse models. They found that, although the pancreas does not normally contain tuft cells, during pancreatitis acinar cells undergo complex changes to become tuft cells, as a normal part of pancreatic injury and recovery. This transformation is similar to a reserve soldier (acinar cell) who must then change from their civilian clothes into that of a soldier (tuft cell) to fight off the enemy of inflammation.

The researchers also observed that the pancreatitis-induced tuft cells secreted IL-25 to promote the immune response, similar to what had previously been found in the intestine. Thus, tuft cells may play a role modulating the immune system during pancreatitis.

The scientists examined tuft cell formation in seven strains of mice to see if there were any differences during the development of pancreatitis. Surprisingly, the team found that tuft cell formation did not occur in all strains of mice. The most genetically diverse animals produced the most tuft cells, suggesting that tuft cell formation is either controlled genetically or by influences on gene expression (epigenetics).

"The genetic susceptibility of tuft cell formation may represent a critical factor in pancreatitis formation, severity and progression to cancer in humans," says Kathleen DelGiorno, first and co-corresponding author of the paper and staff scientist in the Wahl lab. "Our work demonstrates that it's important to use the right mouse model to study pancreatitis and pancreatic cancer for there to be relevance to humans."

The team's work shows that using genetically diverse mice may better represent the complex human genome, allowing for more translatable modeling of disease in the lab, according to Wahl. The findings could mean that some people may be more susceptible to getting pancreatitis than others.

Next, the group plans to follow up on their gene expression analyses to pinpoint which genes control tuft cell formation in pancreatitis and whether tuft cells affect progression to pancreatic cancer. Their biggest hope is that their results will help pave the way for more targeted treatments for pancreatitis and cancer.
Other authors included Linjing Fang, Chi-Yeh Chung, Cynthia Ramos, Natalie Luhtala, Carolyn O'Connor, Tony Hunter and Uri Manor of Salk.

The work was funded by the National Institutes of Health (R01 CA082683, P30 014195, R35 CA197687); The Leona M. and Harry B. Helmsley Charitable Trust (2012-PG-MED002); the Freeberg Foundation; the Copley Foundation; the William H. Isacoff MD Research Foundation for Gastrointestinal Cancer; a T32 training grant (5T32CA9370-34); the Salk Pioneer Award; the Salk Women & Science Special Award; and a Hirshberg Foundation Seed Grant.

About the Salk Institute for Biological Studies:

Every cure has a starting point. The Salk Institute embodies Jonas Salk's mission to dare to make dreams into reality. Its internationally renowned and award-winning scientists explore the very foundations of life, seeking new understandings in neuroscience, genetics, immunology, plant biology and more. The Institute is an independent nonprofit organization and architectural landmark: small by choice, intimate by nature and fearless in the face of any challenge. Be it cancer or Alzheimer's, aging or diabetes, Salk is where cures begin. Learn more at:

Salk Institute

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to